Skip to main content

Table 3 Associations between plasma and IgG N-glycan traits and AIH as compared to healthy controls. Logistic regression was performed between AIH (1) and HC (0), including age, sex and their interaction as co-variates. Only significant associations that passed the set log2 odds ratio threshold (Fig. 2A) are shown. The results of all tests can be found in Supplementary Table 5. To account for multiple testing, p-values have been corrected by the Benjamini-Hochberg procedure using a 5% FDR.

From: Autoimmune hepatitis displays distinctively high multi-antennary sialylation on plasma N-glycans compared to other liver diseases

Derived traits

Description

p-value (age and sex corrected)

Odds ratio [95% CI] (age and sex corrected)

Beta coefficient

Standard error

Glycan type

     

MHy

High mannose to hybrid-type ratio

1.62E-03

0.34 [0.2–0.56]

-1.06

0.27

THy

Total hybrid within total

2.31E-03

2.73 [1.67–4.89]

1.01

0.27

TA2FG0S0

Total fucosylated nongalactosylated nonsialylated A2

2.72E-03

18.55 [4.7-112.74]

2.92

0.81

TA2FS0

Total fucosylated nonsialylated A2

4.41E-03

3.3 [1.76–7.09]

1.19

0.35

Bisection

     

CB

Of complex-type

5.88E-03

3.78 [1.88–9.35]

1.33

0.41

A2B

Of A2

6.10E-03

3.45 [1.79–7.99]

1.24

0.38

A2SB

Of sialylated A2

1.40E-02

2.76 [1.52–5.89]

1.01

0.34

A2FB

Of fucosylated A2

1.63E-03

3.21 [1.87–6.16]

1.17

0.30

A2FSB

Of fucosylated sialylated A2

2.72E-03

2.72 [1.65–4.96]

1.00

0.28

A2S0B

Of nonsialylated A2

2.23E-03

2.93 [1.74–5.39]

1.08

0.29

A2F0S0B

Of nonfucosylated nonsialylated A2

4.28E-03

2.57 [1.55–4.65]

0.94

0.28

A2F0B

Of nonfucosylated A2

2.12E-02

2.93 [1.49–6.89]

1.08

0.39

A2FS0B

Of nonfucosylated sialylated A2

2.72E-03

2.71 [1.64–4.86]

1.00

0.28

Galactosylation

     

CG

Of complex-type

2.72E-03

0.06 [0.01–0.22]

-1.19

0.35

A2G

Of A2

2.77E-03

0.18 [0.06–0.42]

-1.70

0.48

A2FG

Of fucosylated A2

1.60E-03

0.28 [0.14–0.49]

-1.27

0.31

A2SG

Of sialylated A2

1.31E-02

0.33 [0.15–0.63]

-1.10

0.37

A2S0G

Of nonsialylated A2

1.60E-03

0.31 [0.17–0.52]

-1.17

0.29

A2FSG

Of fucosylated sialylated A2

2.72E-03

0.38 [0.21–0.62]

-0.97

0.27

A2FS0G

Of fucosylated nonsialylated A2

1.60E-03

0.32 [0.18–0.54]

-1.13

0.28

A2F0S0G

Of nonfucosylated nonsialylated A2

4.28E-03

0.35 [0.18–0.61]

-1.04

0.30

Sialylation

     

CS

Of complex-type

4.28E-03

0.3 [0.14–0.57]

-1.19

0.35

A4S

Of A4

2.25E-03

2.7 [1.66–4.74]

0.99

0.27

A4GS

Per galactose on A4

1.63E-03

2.88 [1.75–5.16]

1.06

0.27

A4F0GS

Per galactose on nonfucosylated A4

2.72E-03

2.73 [1.64–4.92]

1.00

0.28

IgG glycosylation derived traits

     

IgG1 bisection

IgG1 bisection

1.63E-03

2.55 [1.63–4.22]

0.94

0.24

IgG1 galactosylation

IgG1 galactosylation

3.47E-05

0.21 [0.11–0.37]

-1.55

0.30

IgG1 sialylation

IgG1 sialylation

1.52E-04

0.28 [0.16–0.45]

-1.29

0.27

IgG1 antennary fucosylation

IgG1 antennary fucosylation

1.62E-03

0.34 [0.19–0.56]

-1.07

0.27

IgG2/3 galactosylation

IgG2/3 galactosylation

1.62E-03

0.35 [0.2–0.58]

-1.04

0.26

  1. CI: confidence interval